The South Korean stock market logged its biggest daily loss of more than 5% in eight months on Monday, joining its Asian peers bruised by panic selli...

South Korea’s first alternative stock exchange Nextrade (NXT) started trading on Tuesday, challenging the Korea Exchange’s (KRX) long-sta...

Trading volume in South Korean stock market has surged to its highest level in eight months, with investors piling into defense, nuclear energy, ship...

MSCI, a global index compiler, said on Wednesday it has removed 11 stocks, including Lotte Chemical Corp., from its Korea index without any additions...

Samsung Biologics Co., the world’s largest contract drugmaker, has become South Korea’s third most valuable stock on the country’s ...

Nextrade, South Korea’s first alternative stock exchange, enabling trading of stocks listed on the Kospi and the Kosdaq for 12 hours a day is s...

South Korea’s business-to-business fintech service provider Dozn is planning an initial public offering on the Kosdaq in February for an estima...

The Bank of Korea (BOK) said on Wednesday that the foreign investors' net selling in the South Korean stock market was $3.86 billion in December last...

LG Energy Solution Ltd. reported its first quarterly loss in more than three years on Thursday, adding to concerns that the world’s third-large...

South Korean stocks are expected to bounce back in the new year as their extremely low valuation following investors’ massive sell-offs in 2024...

South Korean stocks showed clear divergences on Wednesday amid a mixed market outlook as President Yoon Suk Yeol’s martial law declaration, rej...

South Korean pension funds continued their Kospi market buying spree for a fourth straight month in November, notching their largest net purchases on...

South Korea's mom-and-pop investors have upped their stake in Indian stocks, hoping that Donald Trump's return to the White House will boost the Sout...

MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. The se...

Korea Investment Management Co. said on Monday it will list the ACE Global AI ASIC exchange-traded fund (ETF) on October 22. The ETF will focus on in...

Foreign investors' appetite for South Korean stocks turned sour with sales of 7.36 trillion won ($5.5 billion) worth of shares on the Korean bourse i...

South Korean online giant Naver Corp. is set to upgrade its digital map service for foreigners to attract more global users as the domestic market gr...

South Korea’s securities exchange operator, Korea Exchange, launched a new corporate value-up index on Tuesday, a key plank for the government&...

South Korea is taking a page from Japan to boost its stock market. There are certainly some low-hanging fruits to pick, but the country’s large...

Mirae Asset Securities announced on Thursday that it has been named “Best Securities House in South Korea” at the Euromoney Securities Ho...

India has emerged as a new darling for South Korean investors actively searching for an alternative to China reeling from multiple economic setbacks....

Mobility, financial services and biotech companies have elbowed out battery and entertainment stocks in the KEDI Innovator ESG 30 Index in an annual ...

Korea Investment Management said on Wednesday it will launch two active exchange-traded funds (ETFs) targeting the Indian market on September 10.The ...

LS Electric Co. plunged more than 9% on Monday, the first day of its inclusion in the Morgan Stanley Capital International (MSCI) Korea Index.On the ...

South Korean exchange-traded funds (ETFs) tracking KEDI, an index set created by The Korea Economic Daily, are booming on growing investor demand for...

South Korea’s individual investors took the recent turmoil in stock markets as an opportunity to buy shares at home and abroad on dips, betting...

South Korea's LS Electric Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index, MSCI announced on Tuesday.MSCI Inc. rebal...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, a...

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump a...